Nashville, TN, United States of America

Rebecca Chinery

This inventor holds 1 USPTO granted patent. Top assignee: Atherogenics, Inc.. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rebecca Chinery. Retrieved from https://idiyas.com/inventor/rebecca-chinery

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Rebecca Chinery

Introduction

Rebecca Chinery is a notable inventor based in Nashville, TN (US). She has made significant contributions to the field of medicine, particularly in the area of cancer treatment. Her innovative approach focuses on enhancing the efficacy of antineoplastic drugs through the use of antioxidants.

Latest Patents

Rebecca Chinery holds a patent titled "Antioxidant enhancement of therapy for hyperproliferative conditions." This patent describes a method to enhance the cytotoxic activity of an antineoplastic drug by administering an effective amount of the drug in combination with an effective cytotoxicity-increasing amount of an antioxidant. The invention also outlines a method to decrease the toxicity of an antineoplastic agent or increase its therapeutic index when treating solid growths of abnormally proliferating cells.

Career Highlights

Chinery is currently associated with Atherogenics, Inc., where she continues to develop her innovative ideas. Her work has the potential to significantly improve cancer treatment outcomes for patients suffering from hyperproliferative conditions.

Collaborations

Some of her notable coworkers include R Daniel Beauchamp and Robert J Coffey, who contribute to the collaborative environment that fosters innovation at Atherogenics, Inc.

Conclusion

Rebecca Chinery's work exemplifies the impact of innovation in the medical field, particularly in enhancing cancer therapies. Her contributions are paving the way for more effective treatments and improved patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…